Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis

被引:2
作者
Rocke, Tonie E. [1 ]
Smith, Susan [1 ]
Marinari, Paul [2 ]
Kreeger, Julie [3 ]
Enama, Jeffrey T. [4 ]
Powel, Bradford S. [4 ]
机构
[1] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA
[2] US Fish & Wildlife Serv, Natl Black Footed Ferret Conservat Ctr, Wellington, CO 80549 USA
[3] US Fish & Wildlife Serv, Natl Black Footed Ferret Conservat Ctr, Wheatland, WY 82201 USA
[4] USA, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD 21702 USA
关键词
black-footed ferrets; F1-V protein; sylvatic plague; vaccine; Yersinia pestis;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Previous studies have established that vaccination of black-footed ferrets (Mustela nigripes) with F1-V fusion protein by subcutaneous (SC) injection protects the animals against plague upon injection of the bacterium Yersinia pestis. This study demonstrates that the F1-V antigen can Also protect ferrets against plague contracted via ingestion of a Y. pestis-infected mouse, a probable route for natural infection. Eight black-footed ferret kits were vaccinated with F1-V protein by SC injection at approximately 60 days-of-age. A booster vaccination was administered 3 mo later via SC injection. Four additional ferret kits received placebos. The animals were challenged 6 wk after the boost by feeding each one a Y. pestis-infected mouse. All eight vaccinates survived challenge, while the four controls succumbed to plague within 3 days after exposure. To determine the duration of antibody postvaccination, 18 additional black-footed ferret kits were vaccinated and boosted with F1-V by SC injection at 60 and 120 days-of-age. High titers to both F1 and V (mean reciprocal titers of 18,552 and 99,862, respectively) were found in all vaccinates up to 2 yr postvaccination, whereas seven control animals remained antibody negative throughout the same time period.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 10 条
  • [1] Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice
    Anderson, GW
    Heath, DG
    Bolt, CR
    Welkos, SL
    Friedlander, AM
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (06) : 793 - 799
  • [2] BARNES AM, 1993, P S MAN PRAIR DOG CO, V93, P28
  • [3] Susceptibility of the Siberian polecat to subcutaneous and oral Yersinia pestis exposure
    Castle, KT
    Biggins, D
    Carter, LG
    Chu, M
    Innes, K
    Wimsatt, J
    [J]. JOURNAL OF WILDLIFE DISEASES, 2001, 37 (04) : 746 - 754
  • [4] Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens
    Glynn, A
    Roy, CJ
    Powell, BS
    Adamovicz, JJ
    Freytag, LC
    Clements, JD
    [J]. INFECTION AND IMMUNITY, 2005, 73 (08) : 5256 - 5261
  • [5] Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine
    Mencher, JS
    Smith, SR
    Powell, TD
    Stinchcomb, DT
    Osorio, JE
    Rocke, TE
    [J]. INFECTION AND IMMUNITY, 2004, 72 (09) : 5502 - 5505
  • [6] Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague
    Powell, BS
    Andrews, GP
    Enama, JT
    Jendrek, S
    Bolt, C
    Worsham, P
    Pullen, JK
    Ribot, W
    Hines, H
    Smith, L
    Heath, DG
    Adamovicz, JJ
    [J]. BIOTECHNOLOGY PROGRESS, 2005, 21 (05) : 1490 - 1510
  • [7] Recombinant F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against virulent Yersinia pestis infection
    Rocke, TE
    Mencher, J
    Smith, SR
    Friedlander, AM
    Andrews, GP
    Baeten, LA
    [J]. JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2004, 35 (02) : 142 - 146
  • [8] ROCKE TE, 2005, RECOVERY BLACK FOOTE, V5293, P243
  • [9] PLAGUE IN A BLACK-FOOTED FERRET (MUSTELA NIGRIPES)
    WILLIAMS, ES
    MILLS, K
    KWIATKOWSKI, DR
    THORNE, ET
    BOERGERFIELDS, A
    [J]. JOURNAL OF WILDLIFE DISEASES, 1994, 30 (04) : 581 - 585
  • [10] Williamson ED, 1999, CLIN EXP IMMUNOL, V116, P107